drug protocol number

OBS16577

drug sponsor

Sanofi

drug study

SARCLISA® ( isatuximab - irfc )

drug trial site

Mouwasat Hospital (Dammam),King Faisal Specialist Hospital and Research Center (Jeddah),King Abdulaziz Medical City NG (Jeddah),King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase